LOCALLY ADVANCED CERVICAL CANCER
Clinical trials for LOCALLY ADVANCED CERVICAL CANCER explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED CERVICAL CANCER trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED CERVICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in cervical cancer trial
Disease control CompletedThis early-phase study tested adding the immunotherapy drug nivolumab to standard chemoradiation for people with locally advanced cervical cancer. The main goal was to check safety and find the right dose, while also looking at how well the combination worked. 21 adults took part…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: Institut Curie • Aim: Disease control
Last updated May 17, 2026 05:44 UTC
-
Immunotherapy boosts standard treatment in cervical cancer trial
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemoradiotherapy helps people with locally advanced cervical cancer live longer without their disease getting worse. About 189 participants received either the standard treatment alone or with atezo…
Matched conditions: LOCALLY ADVANCED CERVICAL CANCER
Phase: PHASE2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 12, 2026 13:43 UTC